{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:01:32Z","timestamp":1770332492885,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81873450"],"award-info":[{"award-number":["81873450"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Open Research Fund from Beijing Advanced Innovation Center for Big Data-Based Precision Medicine, Beijing Tongren Hospital, Beihang University & Capital Medical University","award":["BHTR-KFJJ-202009"],"award-info":[{"award-number":["BHTR-KFJJ-202009"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00432-020-03376-7","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T22:03:03Z","timestamp":1602021783000},"page":"863-869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Using etoposide\u2009+\u2009dexamethasone-based regimens to treat nasal type extranodal natural killer\/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis"],"prefix":"10.1007","volume":"147","author":[{"given":"Liqiang","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9461-2301","authenticated-orcid":false,"given":"Jingwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"3376_CR1","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","volume":"130","author":"E Bergsten","year":"2017","unstructured":"Bergsten E, Horne A, Arico M et al (2017) Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood 130:2728\u20132738. https:\/\/doi.org\/10.1182\/blood-2017-06-788349","journal-title":"Blood"},{"key":"3376_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/bjh.15506","volume":"183","author":"C Bigenwald","year":"2018","unstructured":"Bigenwald C, Fardet L, Coppo P et al (2018) A comprehensive analysis of lymphoma-associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis. Br J Haematol 183:68\u201375. https:\/\/doi.org\/10.1111\/bjh.15506","journal-title":"Br J Haematol"},{"key":"3376_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10428194.2020.1737684","volume":"11","author":"RJ Bubik","year":"2020","unstructured":"Bubik RJ, Barth DM, Hook C et al (2020) Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis. Leuk Lymphoma 11:1\u20139. https:\/\/doi.org\/10.1080\/10428194.2020.1737684","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"3376_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jaci.2020.05.019","volume":"146","author":"Y Cao","year":"2020","unstructured":"Cao Y, Wei J, Zou L et al (2020) Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): a multicenter, single-blind, randomized controlled trial. J Allergy Clin Immunol 146(1):137\u2013146.e3. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.019","journal-title":"J Allergy Clin Immunol."},{"key":"3376_CR5","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8783","author":"Y Chang","year":"2018","unstructured":"Chang Y, Cui M, Fu X et al (2018) Lymphoma associated hemophagocytic syndrome: a single-center retrospective study. Oncol Lett 16:1275-1284.\u00a0https:\/\/doi.org\/10.3892\/ol.2018.8783","journal-title":"Oncol Lett"},{"key":"3376_CR6","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"B Cheson","year":"2014","unstructured":"Cheson B, Fisher R, Barrington S et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059\u20133068. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"issue":"22","key":"3376_CR7","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","volume":"127","author":"JF Emile","year":"2016","unstructured":"Emile JF, Abla O, Fraitag S et al (2016) Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127(22):2672\u20132681. https:\/\/doi.org\/10.1182\/blood-2016-01-690636","journal-title":"Blood"},{"key":"3376_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.blre.2016.05.001","volume":"30","author":"A Hayden","year":"2016","unstructured":"Hayden A, Park S, Giustini D, Lee AY, Chen LY (2016) Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review. Blood Rev 30:411\u2013420. https:\/\/doi.org\/10.1016\/j.blre.2016.05.001","journal-title":"Blood Rev"},{"key":"3376_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M et al (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48:124\u2013131. https:\/\/doi.org\/10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"3376_CR10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ajh.20462","volume":"81","author":"T Henzan","year":"2006","unstructured":"Henzan T, Nagafuji K, Tsukamoto H et al (2006) Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis. Am J Hematol 81:59\u201361. https:\/\/doi.org\/10.1002\/ajh.20462","journal-title":"Am J Hematol"},{"key":"3376_CR11","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1007\/s00277-016-2805-9","volume":"95","author":"J Jia","year":"2016","unstructured":"Jia J, Song Y, Lin N et al (2016) Clinical features and survival of extranodal natural killer\/T cell lymphoma with and without hemophagocytic syndrome. Ann Hematol 95:2023\u20132031. https:\/\/doi.org\/10.1007\/s00277-016-2805-9","journal-title":"Ann Hematol"},{"key":"3376_CR12","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/10245332.2017.1385191","volume":"23","author":"Z Jin","year":"2018","unstructured":"Jin Z, Wang Y, Wang J et al (2018) Multivariate analysis of prognosis for patients with natural killer\/T cell lymphoma-associated hemophagocytic lymphohistiocytosis. Hematology 23:228\u2013234. https:\/\/doi.org\/10.1080\/10245332.2017.1385191","journal-title":"Hematology"},{"key":"3376_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4049\/jimmunol.1302282","volume":"192","author":"TS Johnson","year":"2014","unstructured":"Johnson TS, Terrell CE, Millen SH, Katz JD, Hildeman DA, Jordan MB (2014) Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis. J Immunol 192:84\u201391. https:\/\/doi.org\/10.4049\/jimmunol.1302282","journal-title":"J Immunol"},{"key":"3376_CR14","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/RHU.0b013e31824e8d9b","volume":"18","author":"MP Keith","year":"2012","unstructured":"Keith MP, Pitchford C, Bernstein WB (2012) Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosus. J Clin Rheumatol 18:134\u2013137. https:\/\/doi.org\/10.1097\/RHU.0b013e31824e8d9b","journal-title":"J Clin Rheumatol"},{"issue":"23","key":"3376_CR15","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1182\/blood.2018894618","volume":"133","author":"P La Ros\u00e9e","year":"2019","unstructured":"La Ros\u00e9e P, Horne A, Hines M et al (2019) Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 133(23):2465\u20132477. https:\/\/doi.org\/10.1182\/blood.2018894618","journal-title":"Blood"},{"issue":"7","key":"3376_CR16","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1038\/s41375-020-0891-0","volume":"34","author":"F La Ros\u00e9e","year":"2020","unstructured":"La Ros\u00e9e F, Bremer HC, Gehrke I et al (2020) The Janus kinase 1\/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation. Leukemia 34(7):1805\u20131815. https:\/\/doi.org\/10.1038\/s41375-020-0891-0","journal-title":"Leukemia"},{"key":"3376_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/MD.0000000000000022","volume":"93","author":"J Li","year":"2014","unstructured":"Li J, Wang Q, Zheng W et al (2014) Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore) 93:100\u2013105. https:\/\/doi.org\/10.1097\/MD.0000000000000022","journal-title":"Medicine (Baltimore)"},{"key":"3376_CR18","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/15384047.2017.1295176","volume":"18","author":"N Li","year":"2017","unstructured":"Li N, Zhang L, Liu J et al (2017) A clinical study of 21 patients with hemophagocytic syndrome in 295 cases diagnosed with nasal type, extranodal nature killer\/T cell lymphoma. Cancer Biol Ther 18:252\u2013256. https:\/\/doi.org\/10.1080\/15384047.2017.1295176","journal-title":"Cancer Biol Ther"},{"key":"3376_CR19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2147\/CMAR.S183784","volume":"11","author":"YZ Liu","year":"2019","unstructured":"Liu YZ, Bi LQ, Chang GL, Guo Y, Sun S (2019) Clinical characteristics of extranodal NK\/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis. Cancer Manag Res 11:997\u20131002. https:\/\/doi.org\/10.2147\/CMAR.S183784","journal-title":"Cancer Manag Res"},{"key":"3376_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00005-014-0274-1","volume":"62","author":"I Malinowska","year":"2014","unstructured":"Malinowska I, Machaczka M, Popko K et al (2014) Hemophagocytic syndrome in children and adults. Arch Immunol Ther Exp 62:385\u2013394. https:\/\/doi.org\/10.1007\/s00005-014-0274-1","journal-title":"Arch Immunol Ther Exp"},{"key":"3376_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/pbc.24188","volume":"60","author":"RA Marsh","year":"2013","unstructured":"Marsh RA, Allen CE, McClain KL et al (2013) Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab. Pediatr Blood Cancer 60:101\u2013109. https:\/\/doi.org\/10.1002\/pbc.24188","journal-title":"Pediatr Blood Cancer"},{"key":"3376_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.mayocp.2013.12.012","volume":"89","author":"SA Parikh","year":"2014","unstructured":"Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj AP (2014) Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis. Mayo Clin Proc 89:484\u2013492. https:\/\/doi.org\/10.1016\/j.mayocp.2013.12.012","journal-title":"Mayo Clin Proc"},{"key":"3376_CR23","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","volume":"383","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, L\u00f3pez-Guillermo A, Khamashta MA, Bosch X (2014) Adult haemophagocytic syndrome. Lancet 383:1503\u20131516. https:\/\/doi.org\/10.1016\/S0140-6736(13)61048-X","journal-title":"Lancet"},{"key":"3376_CR24","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.amjmed.2014.04.034","volume":"127","author":"S Riviere","year":"2014","unstructured":"Riviere S, Galicier L, Coppo P et al (2014) Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients. Am J Med 127:1118\u20131125. https:\/\/doi.org\/10.1016\/j.amjmed.2014.04.034","journal-title":"Am J Med"},{"key":"3376_CR25","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1182\/blood-2015-01-551622","volume":"125","author":"AM Schram","year":"2015","unstructured":"Schram AM, Berliner N (2015) How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood 125:2908\u20132914. https:\/\/doi.org\/10.1182\/blood-2015-01-551622","journal-title":"Blood"},{"key":"3376_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1309\/AJCP7YLTQPUSDQ5C","volume":"138","author":"J Sun","year":"2012","unstructured":"Sun J, Yang Q, Lu Z et al (2012) Distribution of lymphoid neoplasms in China: analysis of 4,638 cases according to the World Health Organization classification. Am J Clin Pathol 138:429\u2013434. https:\/\/doi.org\/10.1309\/AJCP7YLTQPUSDQ5C","journal-title":"Am J Clin Pathol"},{"key":"3376_CR27","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues, revised","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL et al (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, revised, 4th edn. IARC, Lyon","edition":"4"},{"key":"3376_CR28","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1182\/blood-2015-05-644914","volume":"126","author":"Y Wang","year":"2015","unstructured":"Wang Y, Huang W, Hu L et al (2015) Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis. Blood 126:2186\u20132192. https:\/\/doi.org\/10.1182\/blood-2015-05-644914","journal-title":"Blood"},{"key":"3376_CR29","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1182\/blood-2017-12-791418","volume":"131","author":"M Yamaguchi","year":"2018","unstructured":"Yamaguchi M, Suzuki R, Oguchi M (2018) Advances in the treatment of extranodal NK\/T-cell lymphoma, nasal type. Blood 131:2528\u20132540. https:\/\/doi.org\/10.1182\/blood-2017-12-791418","journal-title":"Blood"},{"key":"3376_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1746-1596-6-77","volume":"6","author":"QP Yang","year":"2011","unstructured":"Yang QP, Zhang WY, Yu JB et al (2011) Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol 6:77. https:\/\/doi.org\/10.1186\/1746-1596-6-77","journal-title":"Diagn Pathol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03376-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-020-03376-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03376-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:35:53Z","timestamp":1744180553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-020-03376-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3376"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03376-7","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"In our institute, any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes must be registered at clinical trial registry and approved by the Ethic Committee. Our study is a retrospective study. It only collected clinical data of patients, did not interfere with patient\u2019s treatment, and did not pose any risks to the patients' physiology. We did our utmost to protect the patients\u2019 private information from disclosure. Our study is a retrospective study and follows the principles of the Declaration of Helsinki. The Ethics Committee considers that our retrospective study does not need ethical approval. If this situation does not meet the requirements of Journal of Cancer Research and Clinical Oncology, we will try our best to seek approval from the ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}